It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The genitourinary symptom of menopause (GSM) affects up to 65% of women, resulting in symptoms such as vulvovaginal dryness, discomfort, and dysuria, which significantly impacts quality of life. The current assessment methods rely on subjective questionnaires that can be influenced by individual differences, as well as invasive measurements that are time-consuming and not easily accessible. In this study, we explore the potential of a non-invasive and objective assessment tool called diffuse reflectance spectroscopy and imaging (DRSI) to evaluate tissue chromophores, including water, lipid, oxyhemoglobin, and deoxyhemoglobin. These measurements provide information about moisture content, lipid levels, oxygen saturation, and blood fraction, which can serve as surrogate markers for genital estrogen levels. Our findings reveal distinct differences in these chromophores among pre, peri, and postmenopausal subjects. By using lipid and blood fraction tissue chromophores in a K-Nearest Neighbour classifier model, we achieved a prediction accuracy of 65% compared to vaginal maturation index (VMI) that is clinically used to assess estrogen-related hormonal changes. When age was included as the third feature, the accuracy increased to 78%. We believe that by refining the study protocol and configuring the fiber probe to examine tissue chromophores both in the superficial vulva skin for epidermal water content and the deeper layers, DRSI has the potential to provide objective diagnosis and aid in monitoring the treatment outcome of GSM.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Agency for Science, Technology and Research (A*STAR), Institute of Materials Research and Engineering (IMRE), Singapore, Republic of Singapore (GRID:grid.418788.a) (ISNI:0000 0004 0470 809X); A*STAR Skin Research Labs (A*SRL), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore (GRID:grid.185448.4) (ISNI:0000 0004 0637 0221)
2 National University of Singapore, Department of Obstetrics and Gynaecology, NUS Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); National University Hospital, Department of Obstetrics and Gynaecology, Singapore, Singapore (GRID:grid.412106.0) (ISNI:0000 0004 0621 9599); NHS Grampian, Department of Sexual and Reproductive Health, Aberdeen, UK (GRID:grid.411800.c) (ISNI:0000 0001 0237 3845)
3 National University Hospital, Department of Obstetrics and Gynaecology, Singapore, Singapore (GRID:grid.412106.0) (ISNI:0000 0004 0621 9599)
4 National University Hospital, Department of Pathology, Singapore, Singapore (GRID:grid.412106.0) (ISNI:0000 0004 0621 9599)
5 National University of Singapore, Department of Obstetrics and Gynaecology, NUS Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); National University Hospital, Department of Obstetrics and Gynaecology, Singapore, Singapore (GRID:grid.412106.0) (ISNI:0000 0004 0621 9599)